In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Silarus Therapeutics Inc.

www.coipharma.com/portfolio/silarus/

Latest From Silarus Therapeutics Inc.

GSK Buys One Of Eight Firms Formed In VC Partnership With Avalon

Celiac disease specialist Sitari was the first company formed under the six-year collaboration. Three were shut down and Avalon controls the other four, which aren't compatible with GSK's new R&D focus.

Deals Financing

GSK/Avalon Incubator Launches New Firms For Cardiac, Cancer, Lysosomal Storage Disorders

The partnership between GSK and Avalon has now launched six new biotechs in just over two years, each housed at Avalon’s incubator space in San Diego.

BioPharmaceutical United States

“Build-To-Buy” Startup Model Alive And Kicking, Invested Execs Say

VCs and big pharma execs, speaking at CALBIO, said that even in today’s freer economic climate, investing early in startups, with an option to buy when the time is right, is still a viable business strategy.

Strategy Deals

Start-Up Quarterly Statistics, Q3 2014

Start-ups raised $1.19 billion in Q3 2014, 33% more than last quarter. Several reverse licensing alliances were penned; five acquisitions were signed, four in biopharma and one in the device sector.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Silarus Therapeutics Inc.
  • Senior Management
  • Jay Lichter, PhD, Pres. & CEO
    Douglas Downs, CFO
    Marc Nasoff, PhD, CSO
    Sandy Madigan, PhD, CBO
  • Contact Info
  • Silarus Therapeutics Inc.
    Phone: (858) 750-4700
    11099 North Torrey Pines Rd.
    Ste. 290
    La Jolla, CA 92037
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register